Statin use, Candidate Mevalonate Pathway Biomarkers, and Colon Cancer Survival in a Population-Based Cohort Study
Ronan T. Gray(Queen's University Belfast), Helen G. Coleman(Queen's University Belfast), Stephen McQuaid(Queen's University Belfast), Jacqueline A. James(Queen's University Belfast), Peter Bankhead(Institute of Genetics and Cancer), Peter Hamilton(Queen's University Belfast), Chris R. Cardwell(Queen's University Belfast), Victoria Bingham, Claire McGready(Queen's University Belfast), Maurice B. Loughrey(Queen's University Belfast), Anna Gavin(Queen's University Belfast), Roisin O’Neill, Liam Murray(University of Limerick), Manuel Salto‐Tellez(Queen's University Belfast)
Cited by 0
Related Papers
QuPath: Open source software for digital pathology image analysis
|Scientific Reports|2017|8.9k
The Global Landscape of Esophageal Squamous Cell Carcinoma and Esophageal Adenocarcinoma Incidence and Mortality in 2020 and Projections to 2040: New Estimates From GLOBOCAN 2020
|Gastroenterology|2022|1.2k
Progress in cancer survival, mortality, and incidence in seven high-income countries 1995–2014 (ICBP SURVMARK-2): a population-based study
|The Lancet Oncology|2019|1k
QuPath: Open source software for digital pathology image analysis
|bioRxiv (Cold Spring Harbor Laboratory)|2017|809
Hydrogen sulfide is a novel mediator of lipopolysaccharide‐induced inflammation in the mouse
|The FASEB Journal|2005|766